Medacta Group SA (SWX:MOVE)
Switzerland · Delayed Price · Currency is CHF 113.60
-3.20 (-2.74%)
Sep 11, 2026, 5:30 PM CET
Medacta Group Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Medacta Group stock has a consensus rating of "Buy" and an average price target of CHF 178.05. The average 1-year stock price forecast is 56.73% higher than the current stock price, while the lowest is CHF 151.66 (+33.50%) and the highest is CHF 193.23 (+70.10%).
Price Target: CHF 178.05 (+56.73%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Medacta Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Berenberg Bank | Berenberg Bank | Buy Maintains CHF 185.00 → CHF 180.00 | Buy | Maintains | CHF 185.00 → CHF 180.00 | +58.45% | Sep 11, 2026 |
| UBS | UBS | Hold Maintains CHF 151.00 → CHF 148.00 | Hold | Maintains | CHF 151.00 → CHF 148.00 | +30.28% | Jul 21, 2026 |
Financial Forecast
Revenue This Year
763.60M
from 683.83M
Increased by 11.67%
Revenue Next Year
848.42M
from 763.60M
Increased by 11.11%
EPS This Year
5.17
from 4.33
Increased by 19.32%
EPS Next Year
6.04
from 5.17
Increased by 16.75%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.